Current Vascular Pharmacology

Papers
(The median citation count of Current Vascular Pharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside24
Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions23
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports23
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?21
Lifestyle, Maternal Nutrition and Healthy Pregnancy20
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives20
Endothelial Dysfunction and Inflammatory Markers of Vascular Disease19
Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways19
The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention18
Metabolic Adaptations to Pregnancy in Healthy and Gestational Diabetic Pregnancies: The Pancreas - Placenta Axis18
Coronary Calcium Risk Score and Cardiovascular Risk18
Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy14
The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells14
Effects of Maternal Obesity On Placental Phenotype14
Vitamin D and Vascular Disease13
PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials13
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis12
The Myometrium in Pregnant Women with Obesity12
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?11
New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients11
Obesity and Gestational Diabetes in Pregnant Care and Clinical Practice9
Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway9
Non-Alcoholic Fatty Liver Disease and Vascular Disease9
Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia9
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?9
Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class8
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)8
Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i8
Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence8
Assessment and Management of Volume Overload Among Patients on Chronic Dialysis7
Intermittent Fasting as Possible Treatment for Heart Failure7
Effects of Gentiana lutea Root on Vascular Diseases7
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome7
Non-alcoholic Fatty Liver Disease in Children7
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases7
Endocrine Disorders and Peripheral Arterial Disease: A Series of Reviews7
Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Narrative Review7
Features of a Balanced Healthy Diet with Cardiovascular and Other Benefits6
STOPP/START Anti-aggregation and Anticoagulation Alerts in Atrial Fibrillation6
Male Patients with Takayasu Arteritis and Coronary Artery Involvement are Prone to Have Serious Coronary Stenosis and High Mortality6
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 16
Interleukin-10 in the Vasculature: Pathophysiological Implications6
Current Insights on the Role of Irisin in Endothelial Dysfunction6
COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients6
Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study5
Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis5
Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome5
Inflammasomes in the Pathophysiology of Maternal Obesity: Potential Therapeutic Targets to Reduce Long-Term Adverse Health Outcomes in the Mother and Offspring5
Role of Vitamins in Cardiovascular Health: Know Your Facts-Part 25
Contribution of STIM-Activated TRPC-ORAI Channels in Pulmonary Hypertension Induced by Chronic Sustained and Intermittent Hypoxia5
Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention5
Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is the Evidence?5
The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases5
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 25
Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and In vitro Hyperglycaemic Condition5
COVID-19 and Inflammatory Markers5
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?5
Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes5
COVID-19 and Kidney Disease: A Clinical Perspective4
The Neuro-Vascular Consequence of Diabetes: Foot Amputation and Evaluation of its Risk Factors and Health-Related Economic Impact4
Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers4
Comparison of Postprandial Serum Triglyceride and Apolipoprotein B Concentrations between the Two Phases of Menstrual Cycle in Healthy Women4
Have We Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guidelines, and Clinical 4
Selenium, Selenoproteins and 10-year Cardiovascular Risk: Results from the ATTICA Study4
Targeted Therapies in Patients with Pulmonary Arterial Hypertension Due to Congenital Heart Disease4
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease4
Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model4
The cGAS-STING Pathway: A Ubiquitous Checkpoint Perturbing Myocardial Attributes4
Diet and Sudden Death: How to Reduce the Risk4
By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon4
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease4
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabe4
Role of Nicotinic Acetylcholine Receptors in Cardiovascular Physiology and Pathophysiology: Current Trends and Perspectives3
Hypertension-Mediated Organ Damage In Young Patients With First-Diagnosed And Never Treated Systolic Hypertension3
The Emerging Role of CircRNAs in Atherosclerosis3
Exosomes and Exosomal microRNAs in Age-associated Stroke3
The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!3
The Relation Between Red Blood Cell Distribution Width and Coronary Atherosclerotic Plaque Vulnerability Detected by Intracoronary Optical Coherence Tomography3
Role of Glycine and Glycine Receptors in Vascular Endothelium: A New Perspective for the Management of the Post-Ischemic Injury3
Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?3
An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism3
Varicocele at High Altitude; Venous Outflow Restriction by Hypobaric Hypoxia3
Pharmacy and Exercise as Complimentary Partners for Successful Cardiovascular Ageing3
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families2
MDMB-FUBINACA Influences Brain Angiogenesis and the Expression of VEGF, ANG-1, and ANG-22
Epigenetic Changes as a Possible Mechanism Leading to Increased Fetal Cardiovascular Disease Risk in Pregnancies with Gestational Diabetes Mellitus and/or Maternal Hypercholesterolemia2
Diabetic Cardiomyopathy: Clinical and Metabolic Approach2
Current Choice for LDL-C Lowering in High-Risk CVD Patients Intolerant to Statins2
Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin2
Rationale and Design of the ACS-BP Study: Prognostic Value of In-Hospital Blood Pressure and Indices of Atherosclerosis in Acute Coronary Syndromes2
Patients with Polyvascular Disease: A Very High-risk Group2
Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia2
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiac Structural and Electrical Remodeling: From Myocardial Cytology to Cardiodiabetology2
Drugs as Possible Triggers of Takotsubo Cardiomyopathy- Update 2022: Systematic Review2
Cilofexor for the Treatment of Nonalcoholic Steatohepatitis2
Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk2
Gout Flares and Intercritical Gout: Do they Play a Significant Role in Predicting Cardiovascular Events?2
Comparison of Efficacy and Safety between Thrombolysis Plus Anticoagulation vs. Anticoagulation Alone for the Treatment of Acute Submassive Pulmonary Embolism: A Systematic Review and Meta-analysis2
Combination Therapy with Ezetimibe: An Alternative Strategy to Statin Monotherapy in the Management of Patients with Non-cardiac Vascular Disease2
Protective Role of Cytochrome C Oxidase 5A (COX5A) against Mitochondrial Disorder and Oxidative Stress in VSMC Phenotypic Modulation and Neointima Formation2
Ezetimibe and Insulin Resistance2
Antihypertensive Therapy in Patients Receiving Maintenance Hemodialysis: A Narrative Review of the Available Clinical-Trial Evidence2
Arterial Stiffness as a Cardiovascular Risk Factor for the Development of Preeclampsia and Pharmacopreventive Options2
Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review2
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review2
Effect of Gestational Diabetes Mellitus and Hypercholesterolemia on Fetal Cardiovascular Disease Risk: The Role of Epigenetics2
Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity2
The Significance of Renal Function in Response to Cardiac Resynchronisation Therapy – A Piece of a Much Larger Puzzle1
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention1
A Narrative Review of Recent Studies on the Role of Vitamin D in the Prevention of Cardiac and Renal Risk and Additional Considerations for COVID-19 Vulnerability1
Imbalance of Pro- and Anti-inflammatory Cytokines Induced Different Types of Recurrent Atrial Arrhythmias after Drug Eluting Coronary Stent Implantation1
Thyroid Disorders and Peripheral Arterial Disease1
Mechanisms of Endothelial Dysfunction and Cardiovascular System Adaptation1
Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India1
Inflammation and LDL Reduction1
The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes1
Paget’s Disease of Bone and Cardiovascular Risk: A Pilot Study1
Diabetes and Obesity in Pregnancy: From Patients to Molecular Mechanisms1
Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Atrial Fibrillation and Rheumatic Valve Disease1
Novel Therapeutic Strategies for Cardiorenal Protection in Patients with Type 2 Diabetes and Chronic Kidney Disease1
Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study1
Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients1
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management1
Implications of COVID-19 to Stroke Medicine: An Epidemiological and Pathophysiological Perspective1
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency1
Burden of Ischemic Heart Diseases among US States from 1990-20191
Role of Vitamins in Cardiovascular Health: Know Your Facts - Part 11
Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial1
The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease1
MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function via Targeting HIF-1α and E2F31
Thyroid Status and Vascular Risk: An Update1
Aortic Intima-Media Thickness is Increased in Neonates of Mothers with Gestational Diabetes Mellitus: The Role of Thioredoxin-Interacting Protein as a Marker of Oxidative Stress1
Twin Anemia-Polycythemia Sequence (TAPS): From Basic Research to Clinical Practice1
P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?1
Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review1
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality1
The Fundamental Role of Stress Echo in Evaluating Coronary Artery Disease in Specific Patient Populations1
Less Known but Clinically Relevant Comorbidities of Atrial Fibrillation: A Narrative Review1
Rationale for the Concept of Impending Hypertension-Mediated Organ Damage1
Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia1
Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials1
0.030411958694458